Authors
Loading...
Structural analysis reveals active site inhibitors shift full-length BTK conformational equilibria, highlighting long-range allosteric consequences for leukemia drug design.
Joseph et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: